University of Oxford
Oxford, United Kingdom
NCT Number: NCT04435041
18 month study, funded by ESRC COVID-19 research fund. The aim is to explore and support the rapid shift from face-to-face to remote (telephone and video) conversations in primary care. There are three components: a study of clinical interactions and decision making (micro); four locality-based organisational case studies of new models of care (meso); abd a a study of how digital innovation can support NHS infrastructure and vice versa (macro).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Oxford, United Kingdom
18 month study, funded by ESRC COVID-19 research fund. The aim is to explore and support the rapid shift from face-to-face to remote (telephone and video) conversations in primary care. There are three components: a study of clinical interactions and decision making (micro); four locality-based organisational case studies of new models of care (meso); abd a a study of how digital innovation can support NHS infrastructure and vice versa (macro). The methods are mainly qualitative (interviews, virtual ethnography, analysis of documents, micro-analysis of conversations) and are designed to inform action research.
Key deliverables:
At least two evidence-based assessment tools: qualitative (questions for remote assessment of breathlessness) and quantitative (a COVID-19-specific early warning score)
Transferable lessons about how to achieve rapid spread and scale-up, spread in real time through our extensive intersectoral networks
Strengthened infrastructure for supporting digital innovation in the NHS
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Willing and able to give informed consent for participation
Aged 18 years or above
Staff involved in delivering remote-by-default services in the frontline or 'back offices'
Patients/carers who have crossed paths with primary care services during the Covid pandemic.
Pharmacy case studies:
Staff involved in delivering remote pharmacist consultation services in the frontline or 'back offices'
Patients/carers who have crossed paths with community pharmacy primary care services during the COVID-19 pandemic.
Inclusion criteria
for video and telephone consultations
Patients who have remote primary care consultation regarding symptoms associated with COVID-19 and their clinicians (based in Oxford/Thames Valley) who have agreed to participate in the study
Inclusion criteria
for focus groups
Patients that have experienced self-reported 'long Covid' symptoms (for patient only focus groups)
Clinicians that have experienced self-reported 'long Covid' symptoms (for clinician only focus groups)
Exclusion criteria
Patients or clinicians who are too ill to be interviewed
-
Time frame: 18 months
A set of questions and a predictive tool built into electronic records, designed to distinguish people with suspected covid-19 who need to go to hospital from those who can safely be monitored at home. The final Remote COVID-19 Assessment in Primary Care (RECAP) Early warning score score divides people into 'green' (stay at home, self-monitor), amber (professional monitoring e.g., via virtual wards with home oximetry), or red (assess in person promptly).
University of Oxford
Other
Remote-by-Default Care in the COVID-19 Pandemic: Addressing the Micro-, Meso-, and Macro-level Challenges of a Radical New Service Model
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04794829
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial DetailsNCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07722000
COVID-19, Chronic Disease
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT04371432
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial Details